HOME >> MEDICINE >> NEWS
Common anesthetics appear safe for developing fetal brain

ing newborn rat pups in a static chamber, where they inhaled various anesthetics. The results of those studies showed evidence of increased apoptosis, or programmed cell death, in developing nerve cells.

For their new experiments, the Duke team developed a model using pregnant sheep. When the sheep fetus was approximately 17 weeks old an age that approximates a third-trimester human pregnancy the researchers exposed the mother to a three-drug anesthetic combination commonly used to produce general anesthesia. The exposures lasted four hours, a length of time that would encompass most surgeries conducted on pregnant patients.

"We found that four hours of maternal general anesthesia produced an initial increase in systematic oxygenation in the fetus, as well as a sustained increase in oxygenation in the brain," Reynolds said.

The researchers could document cerebral oxygenation in real time because of a system they optimized for fetal applications. The technique, called near-infrared spectroscopy, was originally conceived in the 1970s by Duke faculty member Franz Jobsis.

Light in the near-infrared range can easily pass through skin, bone and other tissues. However, within these frequencies of light, the oxygen-carrying molecules within red blood cells known as hemoglobin absorb light to an extent based on their oxygen content -- giving the researchers a reliable indicator of cerebral oxygenation. Researchers place a fiberoptic probe against the skull of the fetus to measure the changing oxygenation levels of blood circulating in the brain, Reynolds said.

Reynolds said that the increase in oxygenation in the fetal brain is likely due to isoflurane, one of the three commonly used agents, which induced reductions in oxygen metabolism along with increases in cerebral blood flow. Isoflurane is known to produce these actions in the adult brain but it had not been appreciated that such effects could also occur in the fetal brain, he s
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
9-Mar-2005


Page: 1 2 3

Related medicine news :

1. Common schizophrenia symptoms often overlooked by physicians, according to expert panel
2. Common antidepressants lower effects of tamoxifen in many women
3. Common antidepressant may affect youths bone development
4. Common epilepsy treatment to be used for bulimia nervosa
5. Mouth sores: Common complaints of students
6. Common drug, given promptly, reduces incidence of post-traumatic stress disorder, small study finds
7. New Commonwealth Fund analysis compares candidtes health care reform proposals
8. Common heart surgery potentially dangerous
9. Common treatment for cancer pain stimulates breast tumor growth in mice
10. Common diabetes drug causes arteries to spasm, endangering heart
11. Commonly prescribed antibiotic ineffective for treating bronchitis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Common anesthetics appear safe for developing fetal brain

(Date:5/23/2013)... 2013 Canadian Healthy Vending ... Vending Machines, and that's in sync with the preference ... the Canada Organic Trade Association (COTA). The report says ... beverages each year. This makes the burgeoning organic market ... , As a Canadian leader in healthy vending machines, ...
(Date:5/23/2013)... OnSomble, Inc. has partnered with The Aroostook Medical ... and empower nurses to work at their full capacity. ... services and chief nursing officer at The Aroostook Medical ... want to help them take the next step in ... follow, encourage them to take pride in being a ...
(Date:5/23/2013)... Great defined abs are the embodiment of being ... achieve in the gym yet so many fall short of ... goal become a reality. Great abdominal muscles are acquired in ... Scott Tischler of Tischler Brothers Fitness explains four of these ... of great abs. , 1.    Go to bed early. The body ...
(Date:5/23/2013)... Better Life Maids of Portland Oregon is putting on the ... of a kind green house cleaning service in the Portland ... 29th, and a soft opening scheduled for June 3rd, 2013. ... Portland recently and will travel to St. Louis June 26th ... is a lot to take in" stated Heather Richardson. "Better ...
(Date:5/23/2013)... Pittsburgh-based company Automated Security Alert focuses ... own homes for as long as possible. Jason ... commented on how the company differs from other medical ... are numerous companies in the United States that offer ... they are dedicated only to health and well-being while ...
Breaking Medicine News(10 mins):Health News:Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market 2Health News:OnSomble, Inc. Partners with The Aroostook Medical Center to Enhance Nurse Understanding of the Professional Role 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2
(Date:5/23/2013)... DIEGO and PARIS , ... VOLC ), a leading developer and manufacturer of precision ... treatment of coronary and peripheral vascular disease, today announced ... V asodilator I ndependent S tenosis ... breaking clinical trial session at EuroPCR 2013. These prospective ...
(Date:5/23/2013)... -- Nederland keurt als eerste nieuwe vaste-dosis ... BPH Astellas Pharma EUROPE ... gebaseerd in Tokyo  ( ... Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) een handelsvergunning ... handelsvergunning verleend voor VESOMNI is voor "de behandeling van ...
(Date:5/23/2013)... , Switzerland and ... 2013 Cenix BioScience, a ... specialized in RNAi-, miRNA- and high content-driven pharmacology, ... group of companies with a focus on the ... needs, including oncology and companion diagnostics, today announced ...
Breaking Medicine Technology:Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4
Cached News: